A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering the sugars on their surface, hindering the host immune system and avoiding ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Though Gilead Sciences made waves last June with a landmark FDA approval for its twice-yearly HIV preventive Yeztugo (lenacapavir), the first-in-class drug had previously been used as a long-acting ...
I’ve spent much of my career caring for people in places most Americans never see. I’ve worked in refugee camps, on the streets of large cities, in rural communities cut off from care, in clinics ...
New York City health department officials are concerned after recently released data showed a slight uptick in HIV cases – which comes as the federal government proposes cutting funding to HIV ...
Masonia Traylor folded into a ball in the corner of the patient room. "No," the 23-year-old screamed, over and over again. She was HIV-positive. It came as a surprise to the now 38-year-old from ...
A man has become the seventh person to be left HIV-free after receiving a stem cell transplant to treat blood cancer. Significantly, he is also the second of the seven who received stem cells that ...
Researchers led by a team from Mass General Brigham and the Ragon Institute have discovered why some people living with HIV who are given a treatment called broadly neutralizing anti-HIV antibodies ...
Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval molecule as a new anchor treatment for the infectious disease. Integrase strand ...
Robin Lin Miller has previously received research and evaluation funding from the U.S. Department of State, Centers for Disease Control and Prevention, National Institute of Mental Health, National ...
SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...
Some lawmakers and advocates are increasingly uncertain whether critical HIV and AIDS services will survive the federal government’s funding fight. The GOP’s House-passed budget bill seeks to cut over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results